menu
    • menu

    Find Coagulation Factor VIII manufacturers, exporters & distributors on PharmaCompass

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-05-19

    Virtual Booth

    Contact Supplier

    Chirogate is a professional Prostaglandin manufacturer.

    Virtual Booth

    Contact Supplier

    Temad- We think of world-class quality.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass

    Synopsis

    Related ProductsRelated Products

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    1

    API Suppliers

    API Suppliers

    0

    USDMF

    US DMFs Filed

    0

    CEP/COS

    CEP/COS Certifications

    0

    JDMF

    JDMFs Filed

    0

    EU WC

    EU WC

    0

    KDMF

    KDMF

    0

    NDC API

    NDC API

    0

    VMF

    NDC API

    1

    Listed Suppliers

    Other Suppliers

    0INTERMEDIATES

    REF. STANDARDS OR IMPURITIES

    0

    EDQM

    0

    USP

    0

    JP

    0

    Others

    FINISHED DOSAGE FORMULATIONS

    21

    FDF Dossiers

    FDF Dossiers

    0

    FDA Orange Book

    FDA (Orange Book)

    0

    Europe

    Europe

    0

    Canada

    Canada

    0

    Australia

    Australia

    14

    South Africa

    South Africa

    7

    Listed Dossiers

    Listed Dossiers

    0 DRUGS IN DEVELOPMENT

    FDF Dossiers

    DRUG PRODUCT COMPOSITIONS

    0RELATED EXCIPIENT COMPANIES

    0EXCIPIENTS BY APPLICATIONS

    PATENTS & EXCLUSIVITIES

    0

    US Patents

    0

    US Exclusivities

    0

    Health Canada Patents

    API REF. PRICE (USD/KG)

    $
    $ 0

    GLOBAL SALES INFORMATION

    US Medicaid

    NA

    Annual Reports

    670

    Regulatory FDF Prices

    NA

    API/FDF Prices: Book a Demo to
    explore the features and consider
    upgrading later

    MARKET PLACE

    0

    API

    5

    FDF

    DIGITAL CONTENT

    0

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    2

    News #PharmaBuzz

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more

    Global Sales Information

    Do you need Business Intel? Ask us

    Annual Reports

    read-more
    read-more

    01

    Brand Name : NovoEight

    Human Coagulation factor VIII

    arrow
    Bioequity Europe
    Not Confirmed

    Brand Name : NovoEight

    Denmark
    arrow
    Bioequity Europe
    Not Confirmed

    Novo Nordisk

    Human Coagulation factor VIII

    Main Therapeutic Indication : Hematology

    Currency : USD

    2020 Revenue in Millions : 238

    2019 Revenue in Millions : 248

    Growth (%) : -4

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : of which Novoeight

    Human Coagulation Factor VIII

    arrow
    Bioequity Europe
    Not Confirmed

    Brand Name : of which Novoeight

    Denmark
    arrow
    Bioequity Europe
    Not Confirmed

    Novo Nordisk

    Human Coagulation Factor VIII

    Main Therapeutic Indication : Blood Disorders

    Currency : USD

    2018 Revenue in Millions : 203

    2017 Revenue in Millions : 165

    Growth (%) : 23%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : NovoEight

    Human Coagulation factor VIII

    arrow
    Bioequity Europe
    Not Confirmed

    Brand Name : NovoEight

    Denmark
    arrow
    Bioequity Europe
    Not Confirmed

    Novo Nordisk

    Human Coagulation factor VIII

    Main Therapeutic Indication : Hematology

    Currency : USD

    2019 Revenue in Millions : 229

    2018 Revenue in Millions : 203

    Growth (%) : 13

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Market Place

    Do you need sourcing support? Ask us

    FDF DOSSIERS

    read-more
    read-more
    india-flag.png
    Human Coagulation Factor VIII (8500 IU) Vial needed in India [ENA21749]
    A company that focuses on distribution of various finished formulations is looking for suppliers of Human Coagulation Factor VIII (8500 IU) Vial for commercial purposes. The required quantity is 3,000 units. The supplier must support this enquiry with GMP.
    15 Jan 2025

    Reply

    15 Jan 2025

    Reply text-arrow

    Reply Comment (3)

    15 Jan 2025

    Moldova.png
    Tender// Various Finished Dosage Formulations needed in Moldova [ENA11568]
    Center for Centralized Public Procurement in Health is looking for supplies of Various Finished Dosage Formulations for commercial purpose. The deadline is 31-Oct-2021. 1. Cyclosporine (50 mg) Capsules. The required quantity is 25,920 units. 2. Coagulation factor VIII (500 IU) Solution for Injection. The required quantity is 2,000 units. 3. Coagulation factor VIII (1000 IU) Solution for Injection. The required quantity is 6,800 units.
    05 Oct 2021

    Reply

    05 Oct 2021

    Reply text-arrow

    Reply Comment (9)

    05 Oct 2021

    CzechRepublic.png
    Tender// Various Finished Dosage Formulations needed in Czech Republic [ENA11433]
    Ustav hematologie a krevni transfuze is looking for supplies of Various Finished Dosage Formulations for commercial purpose. The deadline is 18-Oct-2021. 1. Coagulation Factor VIII (1000 IU & 2000 IU) Injections. The required quantity is 10,800 units & 3,600 units respectively. 2. Coagulation Factor IX (2000 IU) Injections. The required quantity is 680 units.
    18 Sep 2021

    Reply

    18 Sep 2021

    Reply text-arrow

    Reply Comment (8)

    18 Sep 2021

    Yemen.png
    Various formulations needed in Republic of Yemen [ENA03488]
    A pharmaceutical company specialized in marketing and sales promotion of niche and biotech pharmaceutical products across Yemen territory is looking for suppliers of below products: 1. Human Albumin 2%/50ml | Quantity - 10,000 units 2. Human Factor VIII 500 IU | Quantity - 2,000 units 3. Human Immunoglobulin Antirhesus Rho (D) 1500 IU/ 2500 IU | Quantity - 10,000 units 4. Human Hepatitis B Immunoglobulin 0.4m/200 IU | Quantity - 2,000 units 5. Intravenous Immunoglobulin 10%/50ml | Quantity - 2,000 units
    20 Feb 2019

    Reply

    20 Feb 2019

    Reply text-arrow

    Reply Comment (12)

    20 Feb 2019

    Market Place
    Enquiry// European/North American manufacturers of Normal Human Immunoglobulin (IVIG) 5g and Coagulation factor VIII 250 and 500 IU needed in Sweden [ENA00923]
    A specialized drug provider that protects patients with special drug needs that are hard to access is looking for European/North American manufacturers of Normal Human Immunoglobulin (IVIG) 5G and Coagulation factor VIII 250 and 500 IU (1000-5000 vials).
    17 May 2018

    Reply

    17 May 2018

    Reply text-arrow

    Reply Comment (1)

    17 May 2018

    PharmaCompass
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search